Expert consensus on diagnostic management specification and biomarker disclosure for subjective cognitive decline

The concept of subjective cognitive decline (SCD) is currently receiving much attention, as SCD has a high risk of transitioning to mild cognitive impairment (MCI) and dementia. The ATN biomarker diagnostic framework can accurately diagnose SCD as preclinical Alzheimer′s disease (AD), which is an im...

Full description

Bibliographic Details
Main Author: Neurodegenerative Disease Special Committee, China Association for Promotion of Health Science and Technology
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2024-11-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/2955